Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	9,045	8,717	3,654	4,294	5,092	6,592
Market Cap Growth	125.14%	138.60%	-14.91%	-15.67%	-22.76%	80.99%
Enterprise Value	7,999	7,982	2,482	2,208	3,643	4,155
Last Close Price	93.30	94.50	39.26	46.19	54.26	69.38
PE Ratio	-	-	-	-	-	3.17
PS Ratio	21.57	20.78	12.48	21.88	17.07	95.60
PB Ratio	5.89	5.67	2.38	1.81	1.39	1.57
P/TBV Ratio	6.83	6.59	2.69	2.00	1.49	1.63
EV/Sales Ratio	19.07	19.03	8.48	11.25	12.21	60.25
Debt / Equity Ratio	0.07	0.07	0.11	0.08	0.05	0.01
Net Debt / Equity Ratio	-0.72	-0.72	-0.68	-0.82	-0.37	-0.55
Net Debt / EBITDA Ratio	1.66	1.66	1.24	2.45	2.93	5.01
Net Debt / FCF Ratio	1.71	1.71	1.15	2.41	2.24	7.69
Asset Turnover	0.23	0.23	0.13	0.06	0.07	0.02
Inventory Turnover	12.24	12.24	9.33	17.47	-	-
Quick Ratio	7.87	7.87	5.81	9.89	8.09	14.76
Current Ratio	8.21	8.21	6.11	10.05	8.25	14.91
Return on Equity (ROE)	-46.82%	-46.82%	-44.56%	-42.09%	-12.66%	-17.16%
Return on Assets (ROA)	-24.69%	-24.69%	-23.94%	-15.46%	-7.26%	-8.07%
Return on Capital Employed (ROCE)	-44.60%	-44.60%	-53.30%	-33.20%	-12.70%	-11.80%
Earnings Yield	-7.39%	-7.66%	-22.05%	-28.06%	-8.52%	31.53%
FCF Yield	-7.14%	-7.41%	-24.82%	-18.87%	-11.82%	-4.58%
Dividend Yield	-	-	-	-	0.88%	1.14%
Buyback Yield / Dilution	-0.21%	-0.21%	-0.11%	-0.02%	0.07%	-0.48%
Total Shareholder Return	-0.21%	-0.21%	-0.11%	-0.02%	0.95%	0.66%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.